BR9708908A - Processo para tratamento de inflamação - Google Patents

Processo para tratamento de inflamação

Info

Publication number
BR9708908A
BR9708908A BR9708908A BR9708908A BR9708908A BR 9708908 A BR9708908 A BR 9708908A BR 9708908 A BR9708908 A BR 9708908A BR 9708908 A BR9708908 A BR 9708908A BR 9708908 A BR9708908 A BR 9708908A
Authority
BR
Brazil
Prior art keywords
treating inflammation
inflammation
treating
Prior art date
Application number
BR9708908A
Other languages
English (en)
Inventor
Sidney R Smith
Satwant K Narula
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR9708908A publication Critical patent/BR9708908A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
BR9708908A 1996-05-03 1997-04-29 Processo para tratamento de inflamação BR9708908A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/642,816 US5753218A (en) 1996-05-03 1996-05-03 Method for treating inflammation
PCT/US1997/006802 WO1997041882A1 (en) 1996-05-03 1997-04-29 Method for treating inflammation

Publications (1)

Publication Number Publication Date
BR9708908A true BR9708908A (pt) 1999-08-03

Family

ID=24578143

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708908A BR9708908A (pt) 1996-05-03 1997-04-29 Processo para tratamento de inflamação

Country Status (15)

Country Link
US (1) US5753218A (pt)
EP (1) EP0906118A1 (pt)
JP (1) JP2000509715A (pt)
KR (1) KR20000010706A (pt)
AR (1) AR006932A1 (pt)
AU (1) AU718857B2 (pt)
BR (1) BR9708908A (pt)
CA (1) CA2253312A1 (pt)
HU (1) HUP9903144A3 (pt)
ID (1) ID17194A (pt)
IL (1) IL126759A0 (pt)
NZ (1) NZ332464A (pt)
PE (1) PE64498A1 (pt)
WO (1) WO1997041882A1 (pt)
ZA (1) ZA973707B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US5800268A (en) 1995-10-20 1998-09-01 Molnick; Melvin Method of participating in a live casino game from a remote location
US7067144B2 (en) * 1998-10-20 2006-06-27 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation
MXPA01010480A (es) * 1999-04-13 2002-03-27 Schering Corp Usos novedosos de la proteina 0x2 de mamifero y reactivos relacionados.
US6544504B1 (en) 1999-07-28 2003-04-08 Schering Corporation Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy
WO2001008696A2 (en) * 1999-07-28 2001-02-08 Schering Corporation Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy
AU6517900A (en) * 1999-08-03 2001-02-19 Smith & Nephew, Inc. Controlled release implantable devices
CA2431206C (en) * 2000-12-08 2009-09-01 Takeda Chemical Industries, Ltd. Combination drugs containing anti-sepsis cycloalkene compound
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
WO2003030720A2 (en) * 2001-10-09 2003-04-17 The Children's Hospital Of Philadelphia Materials and methods for preventing or reducing scar formation
WO2003045322A2 (en) * 2001-11-28 2003-06-05 Schering Corporation Method for treating and preventing pancreatitis
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20120195938A1 (en) * 2007-05-30 2012-08-02 James Louis Rutkowski Formulations and methods for recovery from dental surgery
US9511076B2 (en) * 2008-05-30 2016-12-06 Clarion Research Group Formulations and methods for recovery from dental surgery
EP2654756A1 (en) * 2010-12-22 2013-10-30 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound having antibacterial activity
WO2015063613A2 (en) 2013-11-01 2015-05-07 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
KR102624174B1 (ko) * 2020-09-18 2024-01-23 주식회사 아미코젠파마 수가용화된 담즙산을 포함하는 패혈증, 급성 폐손상 질환, 또는 급성 호흡곤란증후군의 예방 또는 치료용 약학 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
WO1989004838A1 (en) * 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US5077284A (en) * 1988-12-30 1991-12-31 Loria Roger M Use of dehydroepiandrosterone to improve immune response
US5231012A (en) * 1989-06-28 1993-07-27 Schering Corporation Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)
EP0502080A4 (en) * 1989-11-21 1993-02-10 The University Of Melbourne Anti-inflammatory compositions and methods
US5300292A (en) * 1991-05-03 1994-04-05 The Regents Of The University Of California Composition and method for treating inflammation
WO1993002693A2 (en) * 1991-08-06 1993-02-18 Schering Corporation Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
US5368854A (en) * 1992-08-20 1994-11-29 Schering Corporation Use of IL-10 to treat inflammatory bowel disease
US5601815A (en) * 1992-08-21 1997-02-11 Schering Corp IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
JPH11510185A (ja) * 1995-08-07 1999-09-07 シェーリング コーポレイション インターロイキン−１０を用いた眼の炎症性状態の処置

Also Published As

Publication number Publication date
AU718857B2 (en) 2000-04-20
ID17194A (id) 1997-12-11
US5753218A (en) 1998-05-19
CA2253312A1 (en) 1997-11-13
AR006932A1 (es) 1999-09-29
HUP9903144A2 (hu) 2000-03-28
NZ332464A (en) 2000-07-28
IL126759A0 (en) 1999-08-17
JP2000509715A (ja) 2000-08-02
PE64498A1 (es) 1998-10-29
ZA973707B (en) 1997-10-29
WO1997041882A1 (en) 1997-11-13
AU2808997A (en) 1997-11-26
HUP9903144A3 (en) 2000-11-28
KR20000010706A (ko) 2000-02-25
EP0906118A1 (en) 1999-04-07

Similar Documents

Publication Publication Date Title
BR9708908A (pt) Processo para tratamento de inflamação
BR9706874A (pt) Processo para tratar uma formação subterrânea
BR9509505A (pt) Processo para formar derivados de aluminio-silicato
BR9701152A (pt) Processo e aparelho para eliminação de interferência
BR9510077A (pt) Aparelho e processo para tratamento e distribuição de águas servidas
BR9707608A (pt) Processo para paquemmento em multicamada
BR9704292A (pt) Processo de e aparelho para expansão de tabaco
BR9709610A (pt) Processo para distribuir artigos absorventes
BR9510034A (pt) Processo para preparação de polietileno
BR9602695A (pt) Composto método e composição para tratamento de distúrbios hiperproliferativos
BR9701330A (pt) Processo e aparelho para refinamento de silício
BR9606782A (pt) Processo para preparar ciclopilacetileno
BR9506542A (pt) Processo para fabricação de artigo absorvente
BR9710099A (pt) Processo para produzir compostos
BR9704986A (pt) Processo de síntese de uréia aperfeiçoado e aparelho para o mesmo
BR9701136A (pt) Processo para obtenção de isoforona
BR9601294A (pt) Composto e processo para preparação do mesmo
BR9708145A (pt) Processo para tratamento de dor de enxaqueca
PT912603E (pt) Processo para preparar certos aza ciclo-hexapeptidos
BR9711578A (pt) Lubrificante para hipercompressor e processo de obten-Æo
BR9501179A (pt) Processo de enxerto e dispositivo para o mesmo
BR9700007A (pt) Processo
BR9404156A (pt) Processo para purificação de indigo
BR9505498A (pt) Processo de secagem e aparelho para secagem
BR9701468A (pt) Processo para passivar agulhas cirúrgicas

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]